Clinical Trial Solutions
To provide pharmaceutical, biosimilar and biotechnology companies with the clinical trial solutions required to bring innovative, new medicines to patients across the globe in the quickest and most cost-effective manner, Aposave has created a new generation of Clinical Trial Solutions service.
Aposave provides a comprehensive range of key comparator sourcing solutions from a wide selection of manufacturers around the globe.
What sets Aposave apart, as a new generation healthcare and pharma services partner, is the way in which we go about sourcing comparator solutions on behalf of our clients within the open market channel.
As well as our individual knowledge and expertise, we have unparalleled access to real-time data relating to the availability of key specialty brands across the whole of the EU. To interpret this data, we have powerful analytical tools which enable us to provide our clients with comprehensive, robust sourcing options. This remarkable platform has been built and developed by our parent company Abacus Medicine over the last 16 years.
- We have access to and full visibility of rolling inventory with 1000’s of SKUs of specialist medicines
- Millions of euros have been invested in data sources, analytics and IT systems which provide both a big picture view and the ability to drill down into detail
At any point in time for a given molecule, we can rapidly assess:
- predictive insights
- what our capability is to source this product
- what the price is likely to be
- when the next batches will be available in every market
- what suppliers have access to the product
- from which countries we can source CoAs
- real-time market intelligence
This provides us with a unique and dynamic picture of the EU market!
This means that we can proactively assess options for our clients in real-time, we can look at market by market differentials and different SKUs, so they can have complete confidence in the advice they receive.
The combination of Aposave experience and state-of-the-art analytics and IT resource has created a unique clinical trials solution for the next generation of pharmaceutical products.
At the GCSG conference in September 2020, we conducted a survey to gain an insight into the key challenges faced by clinical supplies executives.
Ian Hoban, Business Development Director (Clinical Trial Solutions), talks about the risks and the actions that can be implemented to avoid the “COVID Timebomb”.
Case study CTS001
A unique solution to drastically reduce client exposure to unplanned clinical trial costs associated with unpredictable comparator overages.
Case study CTS002
A unique offering for the maximum diversity of batch, expiry, and origin conditions for EU clinical trial material.